| Serum levels of TGFβ, IL-10, IL-17, and IL-23 cytokines in β-thalassemia major patients: the impact of silymarin therapy S Balouchi, M Gharagozloo, N Esmaeil, M Mirmoghtadaei, B Moayedi Immunopharmacology and immunotoxicology 36 (4), 271-274, 2014 | 41 | 2014 |
| Evaluating the Safety and Efficacy of Silymarin in β-Thalassemia Patients: A Review BAS Moayedi Esfahani, N Reisi, M Mirmoghtadaei Hemoglobin 39 (2), 75-80, 2015 | 34 | 2015 |
| Combination therapy of sorafenib with mesenchymal stem cells as a novel cancer treatment regimen in xenograft models of hepatocellular carcinoma I Seyhoun, S Hajighasemlou, S Muhammadnejad, J Ai, M Nikbakht, ... Journal of Cellular Physiology 234 (6), 9495-9503, 2019 | 19 | 2019 |
| Preparation of immunotoxin herceptin-botulinum and killing effects on two breast cancer cell lines S Hajighasemlou, M Alebouyeh, H Rastegar, MT Manzari, ... Asian Pacific journal of cancer prevention 16 (14), 5977-5981, 2015 | 19 | 2015 |
| Novel combination of mesenchymal stem cell-conditioned medium with sorafenib have synergistic antitumor effect of hepatocellular carcinoma cells I Seyhoun, S Hajighasemlou, J Ai, F Hosseinzadeh, M Mirmoghtadaei, ... Asian Pacific Journal of Cancer Prevention: APJCP 20 (1), 263, 2019 | 16 | 2019 |
| Characterization and validation of hepatocellular carcinoma (HCC) xenograft tumor as a suitable liver cancer model for preclinical mesenchymal stem cell studies S Hajighasemlou, S Pakzad, J Ai, S Muhammadnejad, M Mirmoghtadaei, ... Asian Pacific Journal of Cancer Prevention: APJCP 19 (6), 1627, 2018 | 15 | 2018 |
| Study of the effect of silymarin on viability of breast cancer cell lines S Hajighasemlou, M Farajollahi, M Alebouyeh, H Rastegar, MT Manzari, ... Advances in Breast Cancer Research 3 (03), 100-105, 2014 | 13 | 2014 |
| Immunology of aging A Massoud, N Rezaei Springer Science & Business Media, 2013 | 13 | 2013 |
| Sorafenib and mesenchymal stem cell therapy: a promising approach for treatment of HCC S Hajighasemlou, M Nikbakht, S Pakzad, S Muhammadnejad, ... Evidence-Based Complementary and Alternative Medicine 2020, 2020 | 10 | 2020 |
| Antibody production after COVID-19 vaccination in patients with inborn errors of immunity M Nourizadeh, E Feizabadi, M Mirmoghtadaei, A Mohammadi, ... Iranian Journal of Immunology 20 (4), 400-409, 2023 | 3 | 2023 |
| Oxidative stress and aging BASM Esfahani, M Mirmoghtadaei, SB Anaraki Immunology of aging, 323-338, 2013 | 3 | 2013 |
| Anti‐inflammatory effect of mesenchymal stem cells on hepatocellular carcinoma in the xenograft mice model S Hajighasemlou, M Nikbakht, S Pakzad, A Azadbakht, ... Veterinary Medicine and Science 8 (5), 2086-2091, 2022 | 2 | 2022 |
| Kidney tissue engineering in preclinical models of renal failure: a systematic review and meta-analysis M Mirmoghtadaei, AS Khaboushan, B Mohammadi, M Sadr, H Farmand, ... Regenerative Medicine 17 (12), 941-955, 2022 | 1 | 2022 |
| Determining reference ranges for lymphocyte proliferation responses to phytohemagglutinin and Bacillus Calmette–Guérin in Iranian children M Nourizadeh, SA Sarrafzadeh, RS Shoormasti, MR Fazlollahi, S Saghafi, ... Clinical Immunology, 109937, 2024 | | 2024 |
| Clinical Characterization and Mutation Analysis of 13 Iranian Ataxia-Telangiectasia Patients: Introducing Three Novel Mutations M Badalzadeh, MS Bavani, Z Alizadeh, M Mirmoghtadaei, L Shakerian, ... | | 2023 |
| Pancreatic Adenocarcinoma Presenting with Biliary Ureteral Stones: A Case Report H Dialameh, M Mirmoghtadaei, Z Ali, M Khalil, F Namdari, A Karami Translational Research in Urology 4 (4), 154-157, 2022 | | 2022 |
| Research Article Sorafenib and Mesenchymal Stem Cell Therapy: A Promising Approach for Treatment of HCC S Hajighasemlou, M Nikbakht, S Pakzad, S Muhammadnejad, ... | | 2020 |
| The Effect of Silymarin on Serum Concentration of Soluble Apoptosis Markers in β-Thalassemia Major Patients Receiving Desferrioxamine N Esmaeil, M Gharagozloo, B Moayedi, M Mirmoghtadaei, MG Samani Journal of Advances in Medical and Pharmaceutical Sciences 2 (2), 52-56, 2015 | | 2015 |
Saieh HajighasemlouFDCLVerified email at razi.tums.ac.ir
